News & Events about Verastem Inc.
Ticker Report
2 months ago
StockNews.com started coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the ...
StockNews.com started coverage on shares of Verastem (NASDAQ:VSTM Get Rating) in a research note published on Monday morning. The brokerage issued a hold rating on the biopharmaceutical companys stock. A number of other equities research analysts have also recently weighed in on the stock. HC ...
Ticker Report
5 months ago
Principal Financial Group Inc. lowered its stake in shares of Verastem, Inc. (NASDAQ:VSTM Get Rating) by 27.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 200,197 shares of the biopharmaceutical companys stock after selling 74,...
Verastem, Inc. (NASDAQ:VSTM Get Rating) saw a large decline in short interest in the month of June. As of June 30th, there was short interest totalling 4,850,000 shares, a decline of 40.6% from the June 15th total of 8,160,000 shares. Based on an average daily volume of 2,460,000 shares, the days-to...